As if HDL, LDL, and VLDL weren’t enough to track, researchers are discovering other types of lipoproteins that play a role in your CHD risk. Again, the standard cholesterol test doesn’t measure them, but most are included in a complete lipid profile.
Chylomicrons
You probably haven’t heard of this class of lipoproteins, as researchers are just beginning to understand their role as a risk factor in CHD. But chylomicrons (ki-LO-mikrons) give rise to all other forms of lipoproteins. When you eat, the fat in your meal passes through your digestive system into your intestine. There the cells lining the small intestine transform the fat. into small droplets of fat and protein that contain cholesterol and triglycerides. These droplets are the chylomicrons,
They head out of your gut and into your bloodstream, eventually encountering enzymes that break them down into chylomicron remnants. The remnants continue on to your liver, where they’re repackaged as other forms of cholesterol and triglycerides, The reason that statins, the major class of cholesterol-lowering drugs (Zocor, Lipitor. Pravachol, ete.), don’t work very well to lower triglyceride levels is that they don’t seem to affect chylomicrons, the major transporter of triglycerides. (We’ll talk more about statins in Chapter 8.)
Researchers dlon’t know why, but the higher the level of chylomicron remnants in your blood, the greater your risk of CHD. Certain cholesterol-lowering drugs, such as Lopid (gemfibrozil) and other fibrates, help lower your chylomicron level, as do supplements of fish oil (more on this in Chapter 5) There are no established targets for chylomicrons, Because they are transient, they don’t sustain a stable blood level
Lipoprotien
Lipoprotein (a), also known as Lp(a)—doctors call it “el-pee little-a”—is found only the blood of hedgehogs, certain monkeys, and humans. It’s made up of a small portion of LDL, with an adhesive protein (apoprotein A) surrounding it. This gives Lp(a) a Velcro-like stickiness that makes it more likely to cause blood clots and lead to the formation of artery-narrowing plaques. It also seems to prevent clots from dissolving, increasing the danger that a clot will block the flow of blood to your heart or brain. Although Lp(a) carries only a small amount of cholesterol, an elevated level is three to four times more powerful as a marker of CHD than other measures, such as LDL.
If you have high Lp(a), your risk of developing CHD over the next 10 years is 70 percent higher than someone with normal levels. The risk is particularly Although Lp(a) carries significant in women. The landmark Heart and Estrogen/Progestin only a small amount of Replacement Study (HERS) found that women with the highest Lp(a) levels had a 54 percent greater risk of recurrent heart problems than those with the lowest levels. And the farmingham Heart Study found that levels above 30 mg/dl doubled the risk of heart attack in 3,000 women.